{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T03:10:41Z","timestamp":1789873841101,"version":"4.0.1"},"reference-count":50,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2016,2,1]],"date-time":"2016-02-01T00:00:00Z","timestamp":1454284800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,1,5]],"date-time":"2016-01-05T00:00:00Z","timestamp":1451952000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000278","name":"Department for International Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000278","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000866","name":"International AIDS Vaccine Initiative","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000866","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000200","name":"United States Agency for International Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000200","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000866","name":"IAVI","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000866","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000866","name":"IAVI","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000866","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000200","name":"USAID","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000200","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2016,2]]},"DOI":"10.1016\/j.vaccine.2015.12.021","type":"journal-article","created":{"date-parts":[[2016,1,17]],"date-time":"2016-01-17T02:55:19Z","timestamp":1452999319000},"page":"1215-1224","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"title":["Control of HIV-1 replication in vitro by vaccine-induced human CD8+ T cells through conserved subdominant Pol epitopes"],"prefix":"10.1016","volume":"34","author":[{"given":"Tina","family":"Ahmed","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola J.","family":"Borthwick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jill","family":"Gilmour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Hayes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucy","family":"Dorrell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom\u00e1\u0161","family":"Hanke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.vaccine.2015.12.021_bib0255","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1101\/cshperspect.a007054","article-title":"The T-cell response to HIV","volume":"2","author":"Walker","year":"2012","journal-title":"Cold Spring Harb Perspect Med"},{"key":"10.1016\/j.vaccine.2015.12.021_bib0260","doi-asserted-by":"crossref","first-page":"6103","DOI":"10.1128\/JVI.68.9.6103-6110.1994","article-title":"Virus-specific CD8+ CTL activity associated with control of viremia in primary HIV-1 infection","volume":"68","author":"Borrow","year":"1994","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2015.12.021_bib0265","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1126\/science.1143767","article-title":"A whole-genome association study of major determinants for host control of HIV-1","volume":"317","author":"Fellay","year":"2007","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2015.12.021_bib0270","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1084\/jem.20090365","article-title":"The first T cell response to transmitted\/founder virus contributes to the control of acute viremia in HIV-1 infection","volume":"206","author":"Goonetilleke","year":"2009","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2015.12.021_bib0275","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1038\/35085576","article-title":"Evolution and transmission of stable CTL escape mutations in HIV infection","volume":"412","author":"Goulder","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2015.12.021_bib0280","doi-asserted-by":"crossref","first-page":"4650","DOI":"10.1128\/JVI.68.7.4650-4655.1994","article-title":"Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome","volume":"68","author":"Koup","year":"1994","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2015.12.021_bib0285","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1038\/nature10003","article-title":"Profound early control of highly pathogenic SIV by an effector memory T-cell vaccine","volume":"473","author":"Hansen","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2015.12.021_bib0290","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1038\/nature12519","article-title":"Immune clearance of highly pathogenic SIV infection","volume":"502","author":"Hansen","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2015.12.021_bib0295","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1084\/jem.20041251","article-title":"T cell cross-reactivity and conformational changes during TCR engagement","volume":"200","author":"Lee","year":"2004","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2015.12.021_bib0300","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1038\/nm1520","article-title":"CD8+ T-cell responses to different HIV proteins have discordant associations with viral load","volume":"13","author":"Kiepiela","year":"2007","journal-title":"Nat Med"},{"key":"10.1016\/j.vaccine.2015.12.021_bib0305","doi-asserted-by":"crossref","first-page":"e1424","DOI":"10.1371\/journal.pone.0001424","article-title":"Broad and Gag-biased HIV-1 epitope repertoires are associated with lower viral loads","volume":"3","author":"Rolland","year":"2008","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2015.12.021_bib0310","doi-asserted-by":"crossref","first-page":"2473","DOI":"10.1084\/jem.20070784","article-title":"Superior control of HIV-1 replication by CD8+ T cells is reflected by their avidity, polyfunctionality, and clonal turnover","volume":"204","author":"Almeida","year":"2007","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2015.12.021_bib0315","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1038\/ni845","article-title":"HIV-specific CD8+ T cell proliferation is coupled to perforin expression and is maintained in nonprogressors","volume":"3","author":"Migueles","year":"2002","journal-title":"Nat Immunol"},{"key":"10.1016\/j.vaccine.2015.12.021_bib0320","doi-asserted-by":"crossref","first-page":"4781","DOI":"10.1182\/blood-2005-12-4818","article-title":"HIV nonprogressors preferentially maintain highly functional HIV-specific CD8+ T cells","volume":"107","author":"Betts","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.vaccine.2015.12.021_bib0325","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1084\/jem.20081127","article-title":"Public clonotype usage identifies protective Gag-specific CD8+ T cell responses in SIV infection","volume":"206","author":"Price","year":"2009","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2015.12.021_bib0330","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S1471-4906(02)00034-0","article-title":"Will we be able to \u2018spot\u2019 an effective HIV-1 vaccine","volume":"24","author":"Yang","year":"2003","journal-title":"Trends Immunol"},{"key":"10.1016\/j.vaccine.2015.12.021_bib0335","doi-asserted-by":"crossref","first-page":"4832","DOI":"10.1182\/blood-2006-07-037481","article-title":"HIV-1-specific CTLs effectively suppress replication of HIV-1 in HIV-1-infected macrophages","volume":"109","author":"Fujiwara","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.vaccine.2015.12.021_bib0340","first-page":"161","article-title":"Development of a luciferase based viral inhibition assay to evaluate vaccine induced CD8 T-cell responses","volume":"161","author":"Naarding","year":"2013","journal-title":"J Immunol Methods"},{"key":"10.1016\/j.vaccine.2015.12.021_bib0345","doi-asserted-by":"crossref","first-page":"597","DOI":"10.4049\/jimmunol.179.1.597","article-title":"Broad TCR usage in functional HIV-1-specific CD8+ T cell expansions driven by vaccination during highly active antiretroviral therapy","volume":"179","author":"Yang","year":"2007","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2015.12.021_bib0350","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1093\/infdis\/jis379","article-title":"Antiviral inhibitory capacity of CD8+ T cells predicts the rate of CD4+ T-cell decline in HIV-1 infection","volume":"206","author":"Yang","year":"2012","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2015.12.021_bib0355","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1086\/650492","article-title":"Viral inhibition assay: a CD8 T cell neutralization assay for use in clinical trials of HIV-1 vaccine candidates","volume":"201","author":"Spentzou","year":"2010","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2015.12.021_bib0360","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1038\/mt.2013.248","article-title":"Vaccine-elicited human T cells recognizing conserved protein regions inhibit HIV-1","volume":"22","author":"Borthwick","year":"2014","journal-title":"Mol Ther"},{"key":"10.1016\/j.vaccine.2015.12.021_bib0365","doi-asserted-by":"crossref","first-page":"e1004658","DOI":"10.1371\/journal.ppat.1004658","article-title":"Identification of effective subdominant anti-HIV-1 CD8+ T cells within entire post-infection and post-vaccination immune responses","volume":"11","author":"Hancock","year":"2015","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.vaccine.2015.12.021_bib0370","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1111\/j.1600-065X.2010.00968.x","article-title":"Living in a house of cards: re-evaluating CD8+ T-cell immune correlates against HIV","volume":"239","author":"Makedonas","year":"2011","journal-title":"Immunol Rev"},{"key":"10.1016\/j.vaccine.2015.12.021_bib0375","doi-asserted-by":"crossref","first-page":"3120","DOI":"10.1128\/JVI.71.4.3120-3128.1997","article-title":"Suppression of human immunodeficiency virus type 1 replication by CD8+ cells: evidence for HLA class I-restricted triggering of cytolityc and noncytolytic mechanisms","volume":"71","author":"Yang","year":"1997","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2015.12.021_bib0380","doi-asserted-by":"crossref","first-page":"3667","DOI":"10.1128\/JVI.02689-06","article-title":"Control of human immunodeficiency virus type 1 is associated with HLA-B*13 and targeting of multiple gag-specific CD8+ T-cell epitopes","volume":"81","author":"Honeyborne","year":"2007","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2015.12.021_bib0385","doi-asserted-by":"crossref","first-page":"3122","DOI":"10.1128\/JVI.80.6.3122-3125.2006","article-title":"Relative dominance of Gag p24-specific cytotoxic T lymphocytes is associated with human immunodeficiency virus control","volume":"80","author":"Zuniga","year":"2006","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2015.12.021_bib0390","doi-asserted-by":"crossref","first-page":"5540","DOI":"10.1128\/JVI.02031-09","article-title":"Enhanced anti-HIV functional activity associated with Gag-specific CD8 T-cell responses","volume":"84","author":"Julg","year":"2010","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2015.12.021_bib0395","doi-asserted-by":"crossref","first-page":"E1480","DOI":"10.1073\/pnas.1421607112","article-title":"Replicative fitness of transmitted HIV-1 drives acute immune activation, proviral load in memory CD4+ T cells, and disease progression","volume":"112","author":"Claiborne","year":"2015","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.vaccine.2015.12.021_bib0400","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1016\/S0140-6736(08)61591-3","article-title":"Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial","volume":"372","author":"Buchbinder","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2015.12.021_bib0405","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1016\/S0140-6736(08)61592-5","article-title":"HIV-1 vaccine-induced immunity in the test-of-concept Step Study: a case-cohort analysis","volume":"372","author":"McElrath","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2015.12.021_bib0410","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1056\/NEJMoa1310566","article-title":"Efficacy trial of a DNA\/rAd5 HIV-1 preventive vaccine","volume":"369","author":"Hammer","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2015.12.021_bib0415","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1517\/14712598.2014.885946","article-title":"Conserved immunogens in prime-bost strategies for the next-generation HIV-1 vaccines","volume":"14","author":"Hanke","year":"2014","journal-title":"Expert Opin Biol Ther"},{"key":"10.1016\/j.vaccine.2015.12.021_bib0420","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1186\/1479-5876-9-208","article-title":"Definition of the viral targets of protective HIV-1-specific T cell responses","volume":"9","author":"Mothe","year":"2011","journal-title":"J Transl Med"},{"key":"10.1016\/j.vaccine.2015.12.021_bib0425","doi-asserted-by":"crossref","first-page":"e984","DOI":"10.1371\/journal.pone.0000984","article-title":"Design and pre-clinical evaluation of a universal HIV-1 vaccine","volume":"2","author":"Letourneau","year":"2007","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2015.12.021_bib0430","doi-asserted-by":"crossref","first-page":"e157","DOI":"10.1371\/journal.ppat.0030157","article-title":"HIV-1 group M conserved elements vaccine","volume":"3","author":"Rolland","year":"2007","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.vaccine.2015.12.021_bib0435","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1038\/nature14053","article-title":"Broad CTL response is required to clear latent HIV-1 due to dominance of escape mutations","volume":"517","author":"Deng","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2015.12.021_bib0440","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.immuni.2012.11.022","article-title":"Translating HIV sequences into quantitative fitness landscapes predicts viral vulnerabilities for rational immunogen design","volume":"38","author":"Ferguson","year":"2013","journal-title":"Immunity"},{"key":"10.1016\/j.vaccine.2015.12.021_bib0445","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1038\/nm992","article-title":"HIV evolution: CTL escape mutation and reversion after transmission","volume":"10","author":"Leslie","year":"2004","journal-title":"Nat Med"},{"key":"10.1016\/j.vaccine.2015.12.021_bib0450","doi-asserted-by":"crossref","first-page":"e1002041","DOI":"10.1371\/journal.ppat.1002041","article-title":"Protective efficacy of serially up-ranked subdominant CD8+ T cell epitopes against virus challenges","volume":"7","author":"Im","year":"2011","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.vaccine.2015.12.021_bib0455","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.jim.2003.10.017","article-title":"The VITAL assay: a versatile fluorometric technique for assessing CTL- and NKT-mediated cytotoxicity against multiple targets in vitro and in vivo","volume":"285","author":"Hermans","year":"2004","journal-title":"J Immunol Methods"},{"key":"10.1016\/j.vaccine.2015.12.021_bib0460","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1126\/science.270.5243.1811","article-title":"Identification of RANTES, MIP-1 alpha, and MIP-1 beta as the major HIV-suppressive factors produced by CD8+ T cells","volume":"270","author":"Cocchi","year":"1995","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2015.12.021_bib0465","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1182\/blood-2003-12-4341","article-title":"HIV-1-specific cytotoxicity is preferentially mediated by a subset of CD8(+) T cells producing both interferon-gamma and tumor necrosis factor-alpha","volume":"104","author":"Lichterfeld","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.vaccine.2015.12.021_bib0470","doi-asserted-by":"crossref","first-page":"1254031","DOI":"10.1126\/science.1254031","article-title":"HIV transmission. Selection bias at the heterosexual HIV-1 transmission bottleneck","volume":"345","author":"Carlson","year":"2014","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2015.12.021_bib0475","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1038\/nsmb785","article-title":"The stoichiometry of Gag protein in HIV-1","volume":"11","author":"Briggs","year":"2004","journal-title":"Nat Struct Mol Biol"},{"key":"10.1016\/j.vaccine.2015.12.021_bib0480","doi-asserted-by":"crossref","first-page":"5760","DOI":"10.1128\/JVI.03627-14","article-title":"Early kinetics of HLA class I-associated peptidome of MVA.HIVconsv-infected cells","volume":"89","author":"Ternette","year":"2015","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2015.12.021_bib0485","doi-asserted-by":"crossref","first-page":"5330","DOI":"10.1128\/JVI.00020-15","article-title":"Clinical control of HIV-1 by cytotoxic T cells specific for multiple conserved epitopes","volume":"89","author":"Murakoshi","year":"2015","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2015.12.021_bib0490","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1084\/jem.187.10.1647-b","article-title":"Protective immunity does not correlate with the hierarchy of virus-specific cytotoxic T cell responses to naturally processed peptides","volume":"187","author":"Gallimore","year":"1998","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2015.12.021_bib0495","doi-asserted-by":"crossref","first-page":"7399","DOI":"10.1128\/JVI.75.16.7399-7409.2001","article-title":"Two overlapping subdominant epitopes identified by DNA immunization induce protective CD8(+) T-cell populations with differing cytolytic activities","volume":"75","author":"Rodriguez","year":"2001","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2015.12.021_bib0500","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1038\/nm.2089","article-title":"Mosaic HIV-1 vaccines expand the breadth and depth of cellular immune responses in rhesus monkeys","volume":"16","author":"Barouch","year":"2010","journal-title":"Nat Med"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X15017934?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X15017934?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,9,14]],"date-time":"2020-09-14T02:22:00Z","timestamp":1600050120000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X15017934"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2]]},"references-count":50,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2016,2]]}},"alternative-id":["S0264410X15017934"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2015.12.021","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2016,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Control of HIV-1 replication in vitro by vaccine-induced human CD8+ T cells through conserved subdominant Pol epitopes","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2015.12.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}